IRIS Accounts Production v25.2.0.378 00437426 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh004374262023-12-31004374262024-12-31004374262024-01-012024-12-31004374262022-12-31004374262023-01-012023-12-31004374262023-12-3100437426ns15:EnglandWales2024-01-012024-12-3100437426ns14:PoundSterling2024-01-012024-12-3100437426ns10:Director12024-01-012024-12-3100437426ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3100437426ns10:SmallEntities2024-01-012024-12-3100437426ns10:AuditExemptWithAccountantsReport2024-01-012024-12-3100437426ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3100437426ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3100437426ns10:FullAccounts2024-01-012024-12-310043742612024-01-012024-12-3100437426ns10:Director22024-01-012024-12-3100437426ns10:Director32024-01-012024-12-3100437426ns10:RegisteredOffice2024-01-012024-12-3100437426ns5:CurrentFinancialInstruments2024-12-3100437426ns5:CurrentFinancialInstruments2023-12-3100437426ns5:ShareCapital2024-12-3100437426ns5:ShareCapital2023-12-3100437426ns5:SharePremium2024-12-3100437426ns5:SharePremium2023-12-3100437426ns5:CapitalRedemptionReserve2024-12-3100437426ns5:CapitalRedemptionReserve2023-12-3100437426ns5:RetainedEarningsAccumulatedLosses2024-12-3100437426ns5:RetainedEarningsAccumulatedLosses2023-12-3100437426ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3100437426ns5:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3100437426ns5:PlantMachinery2024-01-012024-12-3100437426ns5:IntangibleAssetsOtherThanGoodwill2023-12-3100437426ns5:IntangibleAssetsOtherThanGoodwill2024-12-3100437426ns5:IntangibleAssetsOtherThanGoodwill2023-12-3100437426ns5:PlantMachinery2023-12-3100437426ns5:PlantMachinery2024-12-3100437426ns5:PlantMachinery2023-12-3100437426ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3100437426ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: 00437426 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st December 2024

for

Wallace Manufacturing Chemists Limited

Wallace Manufacturing Chemists Limited (Registered number: 00437426)






Contents of the Financial Statements
for the Year Ended 31st December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 7

Wallace Manufacturing Chemists Limited

Company Information
for the Year Ended 31st December 2024







DIRECTORS: S R G Tate
Mrs M J Tate
R E Warriner





REGISTERED OFFICE: 29a Crown Street
Brentwood
Essex
CM14 4BA





REGISTERED NUMBER: 00437426 (England and Wales)





ACCOUNTANTS: Moulton Johnson Limited
Chartered Accountants
29a Crown Street
Brentwood
Essex
CM14 4BA

Wallace Manufacturing Chemists Limited (Registered number: 00437426)

Balance Sheet
31st December 2024

31.12.24 31.12.23
Notes £ £ £ £
FIXED ASSETS
Intangible assets 4 21,399 22,574
Tangible assets 5 17,785 22,001
39,184 44,575

CURRENT ASSETS
Stocks 1,204,171 1,629,441
Debtors 6 2,177,903 1,817,408
Cash at bank and in hand 590,634 650,935
3,972,708 4,097,784
CREDITORS
Amounts falling due within one year 7 2,324,257 2,398,375
NET CURRENT ASSETS 1,648,451 1,699,409
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,687,635

1,743,984

CAPITAL AND RESERVES
Called up share capital 876 876
Share premium 250 250
Capital redemption reserve 374 374
Retained earnings 1,686,135 1,742,484
SHAREHOLDERS' FUNDS 1,687,635 1,743,984

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Wallace Manufacturing Chemists Limited (Registered number: 00437426)

Balance Sheet - continued
31st December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26th September 2025 and were signed on its behalf by:





S R G Tate - Director


Wallace Manufacturing Chemists Limited (Registered number: 00437426)

Notes to the Financial Statements
for the Year Ended 31st December 2024

1. STATUTORY INFORMATION

Wallace Manufacturing Chemists Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Trademarks are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance and 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2023 - 10 ) .

Wallace Manufacturing Chemists Limited (Registered number: 00437426)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2024

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£
COST
At 1st January 2024 61,016
Additions 4,017
Disposals (10,004 )
At 31st December 2024 55,029
AMORTISATION
At 1st January 2024 38,442
Charge for year 5,192
Eliminated on disposal (10,004 )
At 31st December 2024 33,630
NET BOOK VALUE
At 31st December 2024 21,399
At 31st December 2023 22,574

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
COST
At 1st January 2024 100,424
Additions 8,583
Disposals (20,287 )
At 31st December 2024 88,720
DEPRECIATION
At 1st January 2024 78,423
Charge for year 10,043
Eliminated on disposal (17,531 )
At 31st December 2024 70,935
NET BOOK VALUE
At 31st December 2024 17,785
At 31st December 2023 22,001

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£ £
Trade debtors 600,953 460,523
Other debtors 1,576,950 1,356,885
2,177,903 1,817,408

Wallace Manufacturing Chemists Limited (Registered number: 00437426)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£ £
Trade creditors 316,542 617,529
Amounts owed to group undertakings 838,083 663,083
Taxation and social security 57,167 40,026
Other creditors 1,112,465 1,077,737
2,324,257 2,398,375

8. RELATED PARTY DISCLOSURES

During the year, the company sold goods to companies under common control as follows:
£127,336 (2023: 156,845) to Neo Laboratories Limited.
£155,877 (2023: £147,516) to Norma Chemicals Limited.
£1,277,360 (2023: 1,1526,993) to Savoy Laboratories (International) Limited.

During the year, the company recharged £525,889 (2023: £459,727) of its overheads to Kew Health and Beauty Ltd and Savoy Laboratories (International ) Ltd.

At the year end, the amount due by the company to companies under common control amounted to:
£838,083 (2023: 663,083) to Alinter Limited.
£152,892 (2023: £144,983) to Neo Laboratories Limited.
£59,488 (2023: £67,059) to Norma Chemicals Limited
£497,450 (2023: £488,355) to Savoy Laboratories (International) Limited.
£290,590 (2023: £290,590) to Wallace Pharma Limited.
£2,590 (2023: £2,590) to Midas Healthcare Ltd.
£40,000 (2023: £Nil) to Kew Health & Beauty (Holdings) Ltd.
£2,249 (2023 £1,413 owed by) to Eaton Mayfair Limited.

At the year end, the amount due to the company from companies under common control amounted to:
£5,906 (2023: £1,155 owed to) by Blakeney Homes And Estates Limited.
£6,900 (2023: £6,900) by Bionutra Limited.
£1,465,280 (2023: £1,214,255) by Kew Health And Beauty Limited.
£29,522 (2023 £30,002) by Lomax Healthcare Limited.
£8,664 (2023: £20,580) by Kew Health & Beauty (Manufacturing) Ltd.

9. ULTIMATE CONTROLLING PARTY

The ultimate parent company is Alinter Limited, a company registered in England and Wales. Alinter Limited is controlled by Mr S R G Tate, a director of Wallace Manufacturing Chemists Limited.

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Wallace Manufacturing Chemists Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Wallace Manufacturing Chemists Limited for the year ended 31st December 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Wallace Manufacturing Chemists Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Wallace Manufacturing Chemists Limited and state those matters that we have agreed to state to the Board of Directors of Wallace Manufacturing Chemists Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Wallace Manufacturing Chemists Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Wallace Manufacturing Chemists Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Wallace Manufacturing Chemists Limited. You consider that Wallace Manufacturing Chemists Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Wallace Manufacturing Chemists Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Moulton Johnson Limited
Chartered Accountants
29a Crown Street
Brentwood
Essex
CM14 4BA


26th September 2025